Skip to main content
Clinical Trials/KCT0004214
KCT0004214
Completed
未知

Ocular surface changes after combination therapy of hyaluronate 0.15% and hyaluronate 0.3% in dry eye patients.

Keimyung University Dongsan Medical Center0 sites90 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the eye and adnexa
Sponsor
Keimyung University Dongsan Medical Center
Enrollment
90
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 31, 2018
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individuals aged 19 or over who presented with the following criteria after usage of 0\.15% HA in the run\-in period were enrolled: bilateral DED no less than level 2, tear break\-up time (TBUT) less than 10 seconds, corneal fluorescein staining (CFS) score of at least 1 or more by the National Eye Institute (NEI/Industry) grading system, and 33 or more ocular surface disease index (ODSI) severity scale.

Exclusion Criteria

  • At the baseline examination, patients with mild DED (level 1\), TBUT \>10 seconds, CFS score \<1, and ODSI score \<33 (at end of run\-in period) were excluded. Patients with previous ocular pathologies requiring treatment, previous corneal or intraocular surgery within 6 months of the screening visit, a punctal occlusion procedure within 1 month of the screening visit, use of soft contact lenses during the study, measured intraocular pressure over 25 mmHg at the screening visit, and a significant hypersensitivity reaction to HA, as well as patients who were pregnant, breastfeeding, or planning to become pregnant were also excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials